A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
Clinical trial NCT07780383 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07780383
- Sponsor
- Bristol-Myers Squibb
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-21
- Primary completion
- 2027-06-17
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.